Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jan, 2015 | Pages:
556 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015 Summary Global Markets Direct's, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015', provides an overview of the Chronic Obstructive Pulmonary Disease (COPD)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Chronic Obstructive Pulmonary Disease (COPD) - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Chronic Obstructive Pulmonary Disease (COPD) and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Chronic Obstructive Pulmonary Disease (COPD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Chronic Obstructive Pulmonary Disease (COPD) pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Chronic Obstructive Pulmonary Disease (COPD) - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Chronic Obstructive Pulmonary Disease (COPD) pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents Table of Contents 2 Introduction 8 Chronic Obstructive Pulmonary Disease (COPD) Overview 9 Therapeutics Development 10 Chronic Obstructive Pulmonary Disease (COPD) - Therapeutics under Development by Companies 12 Chronic Obstructive Pulmonary Disease (COPD) - Therapeutics under Investigation by Universities/Institutes 21 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Products Glance 23 Chronic Obstructive Pulmonary Disease (COPD) - Products under Development by Companies 27 Chronic Obstructive Pulmonary Disease (COPD) - Products under Investigation by Universities/Institutes 41 Chronic Obstructive Pulmonary Disease (COPD) - Companies Involved in Therapeutics Development 42 Chronic Obstructive Pulmonary Disease (COPD) - Therapeutics Assessment 144 Drug Profiles 161 Chronic Obstructive Pulmonary Disease (COPD) - Recent Pipeline Updates 424 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects 503 Chronic Obstructive Pulmonary Disease (COPD) - Discontinued Products 519 Chronic Obstructive Pulmonary Disease (COPD) - Product Development Milestones 526 Appendix 534
List of Tables Number of Products under Development for Chronic Obstructive Pulmonary Disease (COPD), H1 2015 31 Number of Products under Development for Chronic Obstructive Pulmonary Disease (COPD) - Comparative Analysis, H1 2015 32 Number of Products under Development by Companies, H1 2015 34 Number of Products under Development by Companies, H1 2015 (Contd..1) 35 Number of Products under Development by Companies, H1 2015 (Contd..2) 36 Number of Products under Development by Companies, H1 2015 (Contd..3) 37 Number of Products under Development by Companies, H1 2015 (Contd..4) 38 Number of Products under Development by Companies, H1 2015 (Contd..5) 39 Number of Products under Development by Companies, H1 2015 (Contd..6) 40 Number of Products under Development by Companies, H1 2015 (Contd..7) 41 Number of Products under Investigation by Universities/Institutes, H1 2015 43 Comparative Analysis by Late Stage Development, H1 2015 44 Comparative Analysis by Clinical Stage Development, H1 2015 45 Comparative Analysis by Early Stage Development, H1 2015 46 Comparative Analysis by Unknown Stage Development, H1 2015 47 Products under Development by Companies, H1 2015 48 Products under Development by Companies, H1 2015 (Contd..1) 49 Products under Development by Companies, H1 2015 (Contd..2) 50 Products under Development by Companies, H1 2015 (Contd..3) 51 Products under Development by Companies, H1 2015 (Contd..4) 52 Products under Development by Companies, H1 2015 (Contd..5) 53 Products under Development by Companies, H1 2015 (Contd..6) 54 Products under Development by Companies, H1 2015 (Contd..7) 55 Products under Development by Companies, H1 2015 (Contd..8) 56 Products under Development by Companies, H1 2015 (Contd..9) 57 Products under Development by Companies, H1 2015 (Contd..10) 58 Products under Development by Companies, H1 2015 (Contd..11) 59 Products under Development by Companies, H1 2015 (Contd..12) 60 Products under Development by Companies, H1 2015 (Contd..13) 61 Products under Investigation by Universities/Institutes, H1 2015 62 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Ache Laboratorios Farmaceuticos S/A, H1 2015 63 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Adamis Pharmaceuticals Corporation, H1 2015 64 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Advinus Therapeutics Ltd., H1 2015 65 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Alba Therapeutics Corporation, H1 2015 66 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Alchemia Limited, H1 2015 67 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by AlgiPharma AS, H1 2015 68 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Amakem NV, H1 2015 69 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Ampio Pharmaceuticals, Inc., H1 2015 70 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Apellis Pharmaceuticals, Inc., H1 2015 71 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Aquinox Pharmaceuticals Inc., H1 2015 72 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Ario Pharma Ltd, H1 2015 73 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Asmacure Ltee, H1 2015 74 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Astellas Pharma Inc., H1 2015 75 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by AstraZeneca PLC, H1 2015 76 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Asubio Pharma Co., Ltd., H1 2015 78 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Axikin Pharmaceuticals, Inc., H1 2015 79 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Basilea Pharmaceutica AG, H1 2015 80 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Beech Tree Labs, Inc., H1 2015 81 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Bioheart, Inc., H1 2015 82 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Biotie Therapies Corp., H1 2015 83 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Boehringer Ingelheim GmbH, H1 2015 84 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by C4X Discovery Ltd, H1 2015 85 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Carolus Therapeutics, Inc., H1 2015 86 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Cellular Biomedicine Group, Inc., H1 2015 87 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Chiesi Farmaceutici SpA, H1 2015 88 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Concert Pharmaceuticals, Inc., H1 2015 89 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Corridor Pharmaceuticals Inc., H1 2015 90 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Cubist Pharmaceuticals, Inc., H1 2015 91 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Cytokinetics, Inc., H1 2015 92 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Daiichi Sankyo Company, Limited, H1 2015 93 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Domainex Ltd., H1 2015 94 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Dong Wha Pharma Co., Ltd., H1 2015 95 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Errant Gene Therapeutics, LLC, H1 2015 96 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Five Prime Therapeutics, Inc., H1 2015 97 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Foresee Pharmaceuticals, LLC, H1 2015 98 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Galapagos NV, H1 2015 99 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by GeneFrontier Corporation, H1 2015 100 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Gilead Sciences, Inc., H1 2015 101 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by GlaxoSmithKline plc, H1 2015 103 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by GlycoMar Limited, H1 2015 104 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Grifols, S.A., H1 2015 105 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2015 106 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by High Point Pharmaceuticals, LLC, H1 2015 107 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Hydra Biosciences, Inc., H1 2015 108 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by iCeutica, Inc., H1 2015 109 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Invion Limited, H1 2015 110 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Jiangsu Hansoh Pharmaceutical Co., Ltd., H1 2015 111 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Johnson & Johnson, H1 2015 112 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by KaloBios Pharmaceuticals, Inc., H1 2015 113 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Kissei Pharmaceutical Co., Ltd., H1 2015 114 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Kyowa Hakko Kirin Co., Ltd., H1 2015 115 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Laboratoires Pierre Fabre SA, H1 2015 116 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by LTT Bio-Pharma Co., Ltd., H1 2015 117 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Medestea Research & Production S.p.A., H1 2015 118 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Microbion Corporation, H1 2015 119 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by MSM Protein Technologies, Inc., H1 2015 120 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by N30 Pharmaceuticals, H1 2015 121 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Nostrum Pharmaceuticals, LLC, H1 2015 122 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Novabiotics Ltd, H1 2015 123 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Novartis AG, H1 2015 124 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Ockham Biotech Limited, H1 2015 125 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by OPKO Health, Inc., H1 2015 126 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Orion Oyj, H1 2015 127 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Otsuka Holdings Co., Ltd., H1 2015 128 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by P2D Bioscience, H1 2015 129 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Panmira Pharmaceuticals, LLC., H1 2015 130 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Peptinnovate Limited, H1 2015 131 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Pfizer Inc., H1 2015 132 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by PharmaLundensis AB, H1 2015 133 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Pharmaxis Limited, H1 2015 134 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Promedior, Inc., H1 2015 135 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Prosonix Ltd, H1 2015 136 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Pulmagen Therapeutics LLP, H1 2015 137 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Pulmatrix, Inc., H1 2015 138 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Qu Biologics Inc., H1 2015 139 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Ranbaxy Laboratories Limited, H1 2015 140 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Re-Pharm Limited, H1 2015 141 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Recipharm AB, H1 2015 142 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Respiratorius AB, H1 2015 143 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Rhizen Pharmaceuticals SA, H1 2015 144 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Rottapharm SpA, H1 2015 145 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by SelectX Pharmaceuticals, Inc., H1 2015 146 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Seoul Pharma Co., Ltd., H1 2015 147 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by SkyePharma PLC, H1 2015 148 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Sparsha Pharma International Pvt. Ltd., H1 2015 149 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Spring Bank Pharmaceuticals, Inc., H1 2015 150 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Stelic Institute & Co., H1 2015 151 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Stempeutics Research Private Limited, H1 2015 152 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by sterna biologicals Gmbh & Co KG, H1 2015 153 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Sucampo Pharmaceuticals, Inc., H1 2015 154 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Sunovion Pharmaceuticals Inc., H1 2015 155 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Syntrix Biosystems, Inc., H1 2015 156 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Takeda Pharmaceutical Company Limited, H1 2015 157 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Teva Pharmaceutical Industries Limited, H1 2015 158 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Theraclone Sciences, Inc., H1 2015 159 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Torrent Pharmaceuticals Limited, H1 2015 160 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Verona Pharma Plc, H1 2015 161 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Yuhan Corporation, H1 2015 162 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Yungjin Pharm Ind. Co., Ltd., H1 2015 163 Chronic Obstructive Pulmonary Disease (COPD) - Pipeline by Zambon Company S.p.A., H1 2015 164 Assessment by Monotherapy Products, H1 2015 165 Assessment by Combination Products, H1 2015 166 Number of Products by Stage and Target, H1 2015 168 Number of Products by Stage and Mechanism of Action, H1 2015 174 Number of Products by Stage and Route of Administration, H1 2015 179 Number of Products by Stage and Molecule Type, H1 2015 181 Chronic Obstructive Pulmonary Disease (COPD) Therapeutics - Recent Pipeline Updates, H1 2015 445 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects, H1 2015 524 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..1), H1 2015 525 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..2), H1 2015 526 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..3), H1 2015 527 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..4), H1 2015 528 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..5), H1 2015 529 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..6), H1 2015 530 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..7), H1 2015 531 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..8), H1 2015 532 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..9), H1 2015 533 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..10), H1 2015 534 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..11), H1 2015 535 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..12), H1 2015 536 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..13), H1 2015 537 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..14), H1 2015 538 Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects (Contd..15), H1 2015 539 Chronic Obstructive Pulmonary Disease (COPD) - Discontinued Products, H1 2015 540 Chronic Obstructive Pulmonary Disease (COPD) - Discontinued Products (Contd..1), H1 2015 541 Chronic Obstructive Pulmonary Disease (COPD) - Discontinued Products (Contd..2), H1 2015 542 Chronic Obstructive Pulmonary Disease (COPD) - Discontinued Products (Contd..3), H1 2015 543 Chronic Obstructive Pulmonary Disease (COPD) - Discontinued Products (Contd..4), H1 2015 544 Chronic Obstructive Pulmonary Disease (COPD) - Discontinued Products (Contd..5), H1 2015 545 Chronic Obstructive Pulmonary Disease (COPD) - Discontinued Products (Contd..6), H1 2015 546
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
